Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Detection of Candidatus Neoehrlichia mikurensis in Norway up to the northern limit of Ixodes ricinus distribution using a novel real time PCR test targeting the groEL gene.

BMC Microbiol. 2019; 
Jenkins A, Raasok C,, Pedersen BN, Jensen K,, Andreassen Å,, Soleng A, Edgar KS, Lindstedt HH, Kjelland V,, Stuen S, Hvidsten D, Kristiansen BE.
Products/Services Used Details Operation
Catalog Antibody Controls In order to provide a quantifiable positive control, a syn- thetic plasmid, pNeo, was constructed according to our specifications (GenScript, Piscataway, NJ). Get A Quote

摘要

Candidatus Neoehrlichia mikurensis is an emerging tick-borne pathogen. It is widely distributed in Ixodes ricinus ticks in Europe, but knowledge of its distribution in Norway, where I. ricinus reaches its northern limit, is limited. In this study we have developed a real time PCR test for Ca. N. mikurensis and used it to investigate the distribution of Ca. N. mikurensis in Norway.,Real time PCR targeting the groEL gene was developed and shown to be highly sensitive. It was used to detect Ca. N. mikurensis in 1651 I. ricinus nymphs and adults collected from twelve locations in Norway, from the eastern Oslo Fjord in the south to near the Arctic Circle in the north. The overall prevalence was 6.5% and varied local... More

关键词

Ixodes ricinus; Neoehrlichia mikurensis; Norway; Scandinavia; Tick-borne diseases; Ticks
XML 地图